Amneal Pharmaceuticals, Inc. (AMRX) › Shares OutstandingAmneal Pharmaceuticals, Inc. (AMRX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2018: 127.25M2019: 132.11M2020: 148.91M2021: 151.82M2022: 150.94M2023: 176.14M2024: 308.98M2025: 324.81M324.81M2018Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025324.81M+5.1%2024308.98M+75.4%2023176.14M+16.7%2022150.94M-0.6%2021151.82M+2.0%2020148.91M+12.7%2019132.11M+3.8%2018127.25M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share